|
249 UniChem “protected
pharmacy” through Pfizer deal UniChem's
decision to work with Pfizer as the single distributor of its medicines
was to “protect pharmacy” from the threat of a logistics
provider, such as DHL, taking on the service. So stated Ornella Barra,
Alliance Boots's wholesale and commercial affairs director, at this year's
UniChem convention, held this week in Barbados
PJ 2007;279:249
Full Text
249 Not providing advanced services
will harm pharmacy's reputation About half
the pharmacies in England are still not providing advanced services,
Sue Sharpe, chief executive of the Pharmaceutical Services Negotiating
Committee, revealed this week at the UniChem convention in Barbados
PJ 2007;279:249
Full Text
249 NPSA issues alert on injectable amphotericin
preparations Confusion between the two forms of
injectable amphotericin has led to a safety alert being issued to health care
staff following two recent deaths
PJ 2007;279:249
Full Text
250 Joint pharmacy/GP service
opportunity in Scotland Community pharmacists in
Scotland could set up new services through a primary care programme announced
by the Scottish Government last week
PJ 2007;279:250
Full Text
250 Call for more training on rational asthma
prescribing Prescribers need further education
about rational prescribing for children with asthma, say researchers
PJ 2007;279:250
Full Text
250 Patients need clearer guidance on blood
tests Health professionals should be more explicit
about whether patients with type 2 diabetes need to monitor their blood glucose
levels themselves, and how often they should do this, researchers say
PJ 2007;279:250
Full Text
251 Direct renin inhibitor
launched as antihypertensive Aliskiren (Rasilez),
the first in a new class of antihypertensives, was launched in the UK by Novartis
this week
PJ 2007;279:251
Full Text
251 Fixed-dose combination of perindopril and
indapamide reduces diabetes mortality Giving a
fixed dose combination antihypertensive to patients with type 2 diabetes, regardless
of blood pressure or existing treatment, cuts the risk of cardiovascular death
by 18 per cent, according to a study of over 11,000 patients
PJ 2007;279:251
Full Text
251 Lloyds heart check campaign Lloydspharmacy
plans to encourage one million men to have heart checks by 2010 as part of its
Million Man Challenge, launched in partnership with HEART UK
PJ 2007;279:251
Full Text
251 Scottish Government Scotland's government re-branded itself this week. It is now called the “Scottish Government”, rather than the previous title of the “Scottish Executive”
PJ 2007;279:251
Full Text
251 CPS website Community
Pharmacy Scotland has launched a new website. It follows the organisation's re-branding
earlier this year and replaces the old Scottish Pharmaceutical General Council
website
PJ 2007;279:251
Full Text
252 Demand for stop smoking
support may have peaked Smokers' desire to kick
the habit prompted by the ban on smoking in public places introduced in England
on 1 July 2007 may have peaked, according to the results of a survey published
this week
PJ 2007;279:252
Full Text
252 Stop smoking for Ramadan campaign starts Community pharmacists in north London are involved in a “Stop Smoking for Ramadan” health promotion campaign
PJ 2007;279:252
Full Text
252 Tobacco aversion pictures Images
illustrating the effects that tobacco can have on health will be printed on all
cigarette packets from Autumn 2008 and other tobacco products from 2009
PJ 2007;279:252
Full Text
252 Drug teams Pharmacists
should be better represented on drug and alcohol action teams to ensure their
role is recognised
PJ 2007;279:252
Full Text
252 High use of pharmacists in Wales Over
three quarters of adults in Wales used the services of a pharmacist between November
2005 and October 2006, the third Welsh Health Survey has found
PJ 2007;279:252
Full Text
253 AstraZeneca and ApoPharma
discredit industry Promotional material sponsored
by AstraZeneca and distributed with the 20 January 2007 issue of The Pharmaceutical
Journal broke the Association of the British Pharmaceutical Industry's code of
practice in seven respects, the Prescription Medicines Code of Practice Authority
has ruled
PJ 2007;279:253
Full Text
253 UEA staff win GSK award Duncan
Craig, head of pharmacy at the School of Chemical Sciences and Pharmacy, University
of East Anglia, and Mike Reading, professor of pharmacy at UEA, have won the
2007 GlaxoSmithKline International Achievement Award for their work in developing
novel and innovative thermal techniques and introducing novel characterisation
methods
PJ 2007;279:253
Full Text
253 Pharmacy innovation rewarded by ABPI Six
pharmacy teams have won this year's Association of the British Pharmaceutical
Industry pharmacist awards for innovative projects improving the quality of prescribing,
dispensing or administration of medicines, and contributing to better patient
access to high quality pharmaceutical care
PJ 2007;279:253
Full Text
253 Proposals for trials units Proposals
for voluntary accreditation of phase I clinical trials units in the UK have been
put forward by the Medicines and Healthcare products Regulatory Agency
PJ 2007;279:253
Full Text
253 CD destruction guidance Brief
guidance on the destruction of Controlled Drugs published by the Department of
Health reminds accountable officers that they can authorise people to witness
the destruction of CDs, but that they must not witness it themselves and must
not authorise anyone who is actively involved with managing CDs
PJ 2007;279:253
Full Text
253 Report forecasts NHS surplus The first quarter report for the NHS in England forecasts a surplus of £983m (1.3 per cent of its total budget) at the end of 2007–08
PJ 2007;279:253
Full Text |
The
Pharmaceutical Journal